Plexus (NASDAQ:PLXS) Issues Q1 2025 Earnings Guidance

Plexus (NASDAQ:PLXS) updated its first quarter 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of 1.520-1.670 for the period, compared to the consensus earnings per share estimate of 1.540. The company issued revenue guidance of $960.0 million-$1.0 billion, compared to the consensus revenue estimate of $1.0 billion. Plexus also updated its Q1 guidance to $1.52-$1.67 EPS.

Plexus Price Performance

Shares of Plexus stock traded up $0.79 during trading on Wednesday, hitting $135.57. The stock had a trading volume of 94,509 shares, compared to its average volume of 126,165. The business has a fifty day moving average of $129.74 and a two-hundred day moving average of $115.48. Plexus has a fifty-two week low of $87.21 and a fifty-two week high of $139.98. The firm has a market cap of $3.69 billion, a P/E ratio of 34.15 and a beta of 0.89. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 0.64.

Plexus (NASDAQ:PLXS) last issued its quarterly earnings results on Wednesday, July 24th. The technology company reported $1.45 earnings per share for the quarter, beating analysts’ consensus estimates of $1.28 by $0.17. The company had revenue of $960.70 million during the quarter, compared to the consensus estimate of $981.32 million. Plexus had a net margin of 2.82% and a return on equity of 9.64%. Plexus’s revenue was down 6.0% on a year-over-year basis. During the same period in the prior year, the company earned $1.32 EPS. On average, sell-side analysts expect that Plexus will post 3.74 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have issued reports on PLXS. Benchmark reaffirmed a “buy” rating and issued a $150.00 price target on shares of Plexus in a report on Monday. Needham & Company LLC boosted their price target on shares of Plexus from $114.00 to $144.00 and gave the company a “buy” rating in a report on Friday, July 26th. Finally, KeyCorp started coverage on shares of Plexus in a research note on Tuesday. They issued a “sector weight” rating for the company. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, Plexus currently has a consensus rating of “Hold” and a consensus target price of $125.25.

Insider Activity

In other Plexus news, CEO Todd P. Kelsey sold 1,000 shares of the stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $123.75, for a total value of $123,750.00. Following the completion of the sale, the chief executive officer now owns 87,026 shares in the company, valued at $10,769,467.50. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Plexus news, CEO Todd P. Kelsey sold 1,000 shares of the company’s stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $123.75, for a total value of $123,750.00. Following the transaction, the chief executive officer now directly owns 87,026 shares of the company’s stock, valued at $10,769,467.50. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Steven J. Frisch sold 6,565 shares of Plexus stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $128.11, for a total value of $841,042.15. Following the sale, the insider now owns 36,118 shares of the company’s stock, valued at approximately $4,627,076.98. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 20,113 shares of company stock worth $2,541,394 in the last 90 days. Company insiders own 2.39% of the company’s stock.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.